Skip to main content

Virtual Clinical Utility Study to Assess Use of a Novel Biomarker in Treatment Decision-Making

For Immunotherapy-Eligible First-Line Advanced Stage NSCLC Patients
Videos — August 15, 2023
David R Gandara, MD
Co-Director, Center for Experimental
Therapeutics In Cancer
Senior Advisor to the Director
UC Davis Comprehensive
Cancer Center Chief Medical Officer, International
Society of Liquid Biopsy